Back to TSHA
ProShare Advisors LLC TSHA Position History
Taysha Gene Therapies, Inc. • Healthcare
Quarters held
5
Latest value
$218K
Q3 2026
Peak value
$289K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $151K |
| Q4 2025 | $289K |
| Q1 2026 | $198K |
| Q2 2026 | $278K |
| Q3 2026 | $218K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $218K | 44.8K | — | — |
| Q2 2026 | $278K | 40.8K | — | — |
| Q1 2026 | $198K | 44.3K | — | — |
| Q4 2025 | $289K | 52.5K | — | — |
| Q3 2025 | $151K | 46.0K | — | — |